Therefore, active genetic testing to identify BRCA1/2 mutation carriers at the onset of breast cancer and continuous long-term monitoring of these patients can provide opportunities to detect BRCA-mutated PC at a resectable stage [12]. Here, BRCA1 is linked to breast carcinoma.